Genetic susceptibility to Dupuytren's disease:: transforming growth factor beta receptor (TGFβR) gene polymorphisms and Dupuytren's disease

被引:28
作者
Bayat, A
Stanley, JK
Watson, JS
Ferguson, MWJ
Ollier, WER
机构
[1] Univ Manchester, Ctr Integrated Genom Med Res, Manchester M13 9PT, Lancs, England
[2] Wythenshawe Hosp, Hand Surg Units, Manchester M23 9LT, Lancs, England
[3] Writhtington Hosp, Hand Surg Units, Wigan WN6 9EP, Lancs, England
[4] Univ Manchester, Sch Biol Sci, Div Cells Immunol & Dev, Manchester M13 9PT, Lancs, England
来源
BRITISH JOURNAL OF PLASTIC SURGERY | 2003年 / 56卷 / 04期
基金
英国医学研究理事会;
关键词
Dupuytren's disease /contracture; transforming growth factor beta receptors; polymorphisms; genetic association; CONTRACTURE; ASSOCIATION; EXPRESSION; TISSUE;
D O I
10.1016/S0007-1226(03)00176-0
中图分类号
R61 [外科手术学];
学科分类号
摘要
Dupuytren's disease (DD) is a benign fibroproliferative disease of unknown cause. It is a familial condition that commonly affects Caucasians. Genetic studies have yet to identify the genes involved in DD. Transforming growth factor beta (TGFbeta) family members are multifunctional; some play a central role in wound healing and fibrosis. Previous studies have implicated TGFbeta cytokines and receptors in DD. In the light of this evidence, TGFbeta receptors represent candidate susceptibility genes for this condition. In this study, we investigated the association of single nucleotide polymorphisms (SNPs) in TGFbeta receptors one, two and three (TGFbetaRI, RII and RIII) with the risk of DD formation. A polymerase chain reaction-restriction fragment length polymorphism method was used for genotyping novel and known TGFbeta receptor polymorphisms. DNA samples from 183 DD patients and 181 controls were examined. There was a statistically significant difference (p < 0.05) in genotype frequency distributions between cases and controls for TGFbetaRI polymorphisms in the recessive model. However, there were no significant difference in genotype or allele frequency distributions between cases and controls for the TGFbetaRII and TGFbetaRIII SNPs. (C) 2003 Published by Elsevier Ltd on behalf of The British Association of Plastic Surgeons. All rights reserved.
引用
收藏
页码:328 / 333
页数:6
相关论文
共 24 条
  • [1] COMPARATIVE EFFECTS OF GROWTH-FACTORS ON FIBROBLASTS OF DUPUYTRENS TISSUE AND NORMAL PALMAR FASCIA
    ALIOTO, RJ
    ROSIER, RN
    BURTON, RI
    PUZAS, JE
    [J]. JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1994, 19A (03): : 442 - 452
  • [2] The role of transforming growth factor beta in Dupuytren's disease
    Badalamente, MA
    Sampson, SP
    Hurst, LC
    Dowd, A
    Miyasaka, K
    [J]. JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1996, 21A (02): : 210 - 215
  • [3] ABNORMAL GROWTH-FACTOR AND CYTOKINE EXPRESSION IN DUPUYTREN CONTRACTURE
    BAIRD, KS
    CROSSAN, JF
    RALSTON, SH
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1993, 46 (05) : 425 - 428
  • [4] Genetic susceptibility in Dupuytren's disease:: Lack of association of a novel transforming growth factor β2 polymorphism in Dupuytren's disease
    Bayat, A
    Alansar, A
    Hajeer, AH
    Shah, M
    Watson, JS
    Stanley, JK
    Ferguson, MWJ
    Ollier, WER
    [J]. JOURNAL OF HAND SURGERY-BRITISH AND EUROPEAN VOLUME, 2002, 27B (01) : 47 - 49
  • [5] Genetic susceptibility in Dupuytren's disease -: TGF-β1 polymorphisms and Dupuytren's disease
    Bayat, A
    Watson, JS
    Stanley, JK
    Alansari, A
    Shah, M
    Ferguson, MWJ
    Ollier, WER
    [J]. JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 2002, 84B (02): : 211 - 215
  • [6] Berndt A, 1995, HISTOCHEM J, V27, P1014
  • [7] Mechanisms of disease:: Role of transforming growth factor β in human disease.
    Blobe, GC
    Schiemann, WP
    Lodish, HF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (18) : 1350 - 1358
  • [8] Prolonged, contemporaneous administration of pilocarpine and timolol increases the aqueous humor pilocarpine levels in rabbits
    Burgalassi, S
    Chetoni, P
    Panichi, L
    Saettone, MF
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 1999, 15 (01) : 1 - 7
  • [9] The 3′ untranslated region of messenger RNA:: A molecular 'hotspot' for pathology?
    Conne, B
    Stutz, A
    Vassalli, JD
    [J]. NATURE MEDICINE, 2000, 6 (06) : 637 - 641
  • [10] GABBIANI G, 1972, AM J PATHOL, V66, P131